Contents

Current Pharmaceutical Design, Volume 13 - Number 20

Editorial [Hot Topic: Angiogenesis and Anti-Angiogenesis (Executive Editor: Maurizio Botta)]

, 13(20): 2024

Maurizio Botta


DOI: 10.2174/138161207781039698




Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies

, 13(20): 2025 - 2044

M. Rusnati and M. Presta


DOI: 10.2174/138161207781039689




Interaction of Heparins with Fibroblast Growth Factors: Conformational Aspects

, 13(20): 2045 - 2056

Marco Guerrini, Milos HricovIni and Giangiacomo Torri


DOI: 10.2174/138161207781039733




Heparanase: Structure, Biological Functions, and Inhibition by Heparin-Derived Mimetics of Heparan Sulfate

, 13(20): 2057 - 2073

Israel Vlodavsky, Neta Ilan, Annamaria Naggi and Benito Casu


DOI: 10.2174/138161207781039742




Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

, 13(20): 2074 - 2086

K.N. Sulochana and R. Ge


DOI: 10.2174/138161207781039715




Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors

, 13(20): 2087 - 2100

Elisa Nuti, Tiziano Tuccinardi and Armando Rossello


DOI: 10.2174/138161207781039706




Chondromodulin-I and Tenomodulin: The Negative Control of Angiogenesis in Connective Tissue

, 13(20): 2101 - 2112

Chisa Shukunami and Yuji Hiraki


DOI: 10.2174/138161207781039751




Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications

, 13(20): 2113 - 2117

Shin-ichiro Miura and Keijiro Saku


DOI: 10.2174/138161207781039724




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science